CT Medical Sales

CT Medical Sales We specialise in providing shockwave, laser and Tecar therapy solutions to clinical teams across the UK.

Authorised distributor for EMS Swiss DolorClast products and Wintecare, we are committed to enhancing patient care

03/05/2026

🧭Where do we go from here?

This research doesn’t give us all the answers, but it moves the field forward.👏👏👏

It highlights that:
➡️ Mechanical therapies like rESWT interact with neuromuscular biology in specific, measurable ways
➡️ Postsynaptic organisation may influence treatment response
➡️Recovery after exposure is rapid, suggesting functional modulation rather than damage
➡️ Mechanobiology could shape future approaches to spasticity management

For clinicians using EMS radial shockwave devices, this reinforces the importance of dose, parameters, and clinical reasoning.

CT Medical will continue sharing emerging evidence to help practitioners deliver safe, informed, patient‑centred care.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

02/05/2026

📣Why This Matters for Spasticity Treatment...

Spasticity is multifactorial.

Tone, reflex loops, sensory input, and neuromuscular junction behaviour all play a role.

This study adds to a growing body of evidence suggesting that rESWT may:
➡️ Influence neuromuscular signalling
➡️ Temporarily alter motor output
➡️ Provide a window for improved movement, stretching, or functional therapy
➡️ Do so without pharmacological side‑effects

Understanding the mechanisms helps clinicians choose when, how, and for whom rESWT may be beneficial.
[mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

If you’d like to explore how this evidence informs clinical practice, call us...

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

01/05/2026

⚠️What This Doesn’t Mean...

The authors are clear:
The data do not show direct disruption of the neuromuscular junction or acetylcholine receptor clusters.

🔎Instead, the findings suggest:
➡️ Mechanical stimulation interacts with neuromuscular systems in parameter‑specific ways
➡️ Proteins involved in receptor organisation may modulate sensitivity to shock waves
➡️ The response is functional, not necessarily structural

For clinicians, this reinforces a key message:
rESWT is not “breaking up” tissue it’s modulating biological behaviour.
[mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

Want to understand how these findings translate to practice? Let’s discuss.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

30/04/2026

🔎The Role of RPY‑1 (The Worm Version of Rapsyn)

Rapsyn is essential for clustering acetylcholine receptors at the neuromuscular junction.

In humans, it helps stabilise the postsynaptic membrane, a structure that may be relevant in spasticity.
In the study:
➡️Worms lacking RPY‑1 responded differently to rESWT
➡️ Differences were most obvious at ‘higher exposure levels’
➡️ This suggests that postsynaptic organisation may influence how tissues respond to mechanical stimulation

This doesn’t prove structural damage, but it does suggest that NMJ biology matters when applying rESWT.
[mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

Let’s keep the discussion going, how do you see this shaping future practice?

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

29/04/2026

What Happens When rESWT Hits the Neuromuscular System?🤔

In the study, exposure to radial shock waves caused immediate and noticeable locomotor impairments in the worms.
Importantly:
➡️ The effects were strongest right after treatment
➡️Most changes were reversible within hours
➡️ The response depended on the intensity and number of shock waves delivered

This mirrors what clinicians often observe:
rESWT can temporarily alter tone, movement, or comfort, but the system tends to recover quickly.
[mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

Interested in the mechanobiology behind rESWT? Join the conversation.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

28/04/2026

🔎Why Look at Worms When Studying Spasticity?

It sounds odd, but C. elegans is a powerful model for neuromuscular research.
They have:
➡️ A simple, well‑mapped nervous system
➡️Clear locomotor patterns
➡️A homolog of rapsyn (called RPY‑1), a key protein involved in clustering acetylcholine receptors at the neuromuscular junction

The new study used this model to ask a clinically relevant question:
Do proteins involved in postsynaptic receptor organisation influence how tissues respond to radial shock waves? [mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

Understanding this helps us refine how rESWT might be used in conditions like spasticity.

Curious how this applies in clinic? Start a conversation with us.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

27/04/2026

This week at CT Medical, we turn our attention to Spasticity: More Than “Tight Muscles”

🤚Spasticity isn’t just stiffness...

It’s a complex neuromuscular condition involving exaggerated stretch reflexes, altered motor control, and changes at the level of the spinal cord and neuromuscular junction.

Clinicians use a range of tools to manage it, from stretching and neurorehab to pharmacological options. Increasingly, radial shockwave therapy (rESWT) is being explored as a non‑invasive adjunct.

But ‘how’ does rESWT influence neuromuscular behaviour?

A new study using C. elegans offers fresh clues about what might be happening at the neuromuscular junction.
[mdpi.com](https://www.mdpi.com/2227-9059/14/5/960)

Discover more about rESWT and neuromuscular applications. Message the team.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

🔎Across this series we’ve looked at men’s health...ED assessment, first line care, the science behind Focus Shockwave, t...
26/04/2026

🔎Across this series we’ve looked at men’s health...

ED assessment, first line care, the science behind Focus Shockwave, the evidence base, and why device quality matters.
The takeaway is simple: for the right patients, EMS Swiss DolorClast Focus shockwave can offer real, measurable benefit as shown in recent systematic reviews.

But as always, success comes from good clinical implementation, not just the technology.
If you’re considering adding Focus shockwave to your pathway, think about:
👉 Clear patient selection
👉 Transparent consent and expectations
👉 A consistent treatment protocol
👉 Outcome measures (IIEF/EHS) and follow up
👉 How it complements your existing first-line care

This is a patient choice intervention, for well-selected men with vasculogenic ED, it can be a valuable, non-invasive, drug-free option alongside standard care.
If you’d like support with pathway design, training, clinical literature, peer connections, or a hands on demo of the EMS Swiss DolorClast Focus, talk to Chris and the CT Medical team.
They can help you integrate Focus Shockwave into your men’s health service with confidence

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

25/04/2026

A systematic review and meta-analysis (PubMed) shows that LI ESWT can improve erectile function scores (IIEF/EHS), especially in men with mild–to–moderate vasculogenic ED.

The results are positive, but like most regenerative treatments, they’re not identical across all studies. Different devices, energies and protocols mean outcomes vary.

What we can say confidently is this: for the right patients, Focus Shockwave works, and more research is coming.
When delivered with a high-precision system like EMS Swiss DolorClast Focus, clinics can offer a consistent, non-invasive, drug-free option alongside standard ED care.

It’s not a cure-all, but it is another evidence-supported line of treatment that expands patient choice and fits naturally into a modern ED pathway.

If you want the key papers, protocol guidance, or to see the DolorClast Focus in action, ask Chris and the CT Medical team for a demo.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

24/04/2026

Why EMS Swiss DolorClast Focus stands out…🎯

The EMS Swiss DolorClast Focus is a piezoelectric focused shockwave system built for accuracy, consistency and patient comfort.

It delivers precise, high quality energy exactly where you need it, which is essential when treating sensitive structures like the corpora cavernosa in vasculogenic ED.

What makes it so effective:
👉 Direct, accurate focusing for predictable results
👉 Stable, high-energy densities linked to stronger regenerative responses
👉 Simple depth control using three gel pads
👉 More comfortable than many other focused systems
👉 Intuitive interface with guided protocols and real-time monitoring

For clinics, this means reliable, repeatable, focused shockwave therapy, and for the right patients, a non-invasive, drug-free treatment option that fits naturally into a modern ED pathway.

If you want to see the system in action or get clinical literature, ask Chris and the CT Medical team for a demo.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

Focus… why it matters for vasculogenic ED👍Swiss DolorClast Focus Shockwave delivers focused acoustic pulses into the ere...
23/04/2026

Focus… why it matters for vasculogenic ED👍

Swiss DolorClast Focus Shockwave delivers focused acoustic pulses into the erectile tissue. These pulses create controlled mechanical stress at a cellular level, which triggers a regenerative response rather than simply masking symptoms.

In vasculogenic ED, where the core problem is poor blood flow, this matters because Focus Shockwave has been shown to:
➡️Stimulate angiogenesis: encouraging new microvessels to form, improving pe**le blood supply
➡️ Enhance nitric oxide (NO) signalling: supporting smooth muscle relaxation and better erectile response
➡️Recruit endothelial progenitor cells: helping repair damaged vascular tissue
➡️Improve cavernosal haemodynamics: some studies show improved peak systolic velocity and pe**le blood flow metrics

This is why Focus Shockwave is considered a regenerative option: it aims to improve the underlying vascular function rather than offering a temporary boost like medication.

💉It’s non invasive, drug free, and delivered in short outpatient sessions, which makes it a useful option for men who prefer to avoid medication or who don’t respond well to PDE5 inhibitors.

For the right patients, especially those with mild–moderate vasculogenic ED, it becomes another valuable line of treatment in a modern ED pathway.

If you’d like to see how the EMS Swiss DolorClast Focus system delivers this energy consistently, or want clinical papers, protocols or a hands on demo, ask Chris and the CT Medical team.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

First line ED care and where Focus Shockwave may fit…🤔First line ED care is usually simple: • Lifestyle changes (weight,...
22/04/2026

First line ED care and where Focus Shockwave may fit…🤔

First line ED care is usually simple:
• Lifestyle changes (weight, activity, smoking, alcohol)
• Treating comorbidities like diabetes or hypertension
• PDE5 inhibitors (sildenafil, tadalafil)
• Devices when meds aren’t suitable

👉But patient preference really matters; some want medication, some want non-drug options, some want to avoid anything invasive.

Being upfront about side effects, invasiveness and realistic expectations helps men choose the option that genuinely fits their needs, exactly the approach supported by the EAU guidelines.

And this is where Focus Shockwave becomes a useful addition to the pathway. For the right patients, having a non-invasive, drug-free, regenerative-focused option expands choice and gives clinics another evidence-based line of treatment alongside first-line care.

Every patient is different, adding EMS Swiss DolorClast Focus simply gives you one more clinically grounded option to offer.
If you’d like support designing your pathway or deciding where Focus Shockwave fits, talk to Chris and the CT Medical team.

📞 07469 241209
📧 chris@ctmedsales.co.uk
🌐 https://book.ctmedical.co.uk/upgrade-your-clinic

Address

Amersham
HP65RT

Telephone

+447469241209

Website

Alerts

Be the first to know and let us send you an email when CT Medical Sales posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CT Medical Sales:

Shortcuts

Share

Category